trending Market Intelligence /marketintelligence/en/news-insights/trending/zYP37sGaW9fHFwBiJ6O6eA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Endonovo announces reverse stock split at 1-for-1000 ratio

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive


Endonovo announces reverse stock split at 1-for-1000 ratio

Endonovo Therapeutics Inc. will conduct a reverse stock split of its shares at a 1-for-1,000 ratio.

The split will cut the Woodland Hills, Calif.-based medical device company's estimated 1,005,306,406 outstanding shares of common stock down to approximately 100,530. Following the reverse stock split, fractional shares will round up to a full share for the stockholders who hold them.

The company's exchange agent, Equity Stock Transfer, will guide shareholders on how to exchange existing share certificates for new ones post-split.

Endonovo will continue to trade on the OTCQB under its existing ticker of ENDVD after the reverse stock split.